Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-01-25

FDA Approved: CABERGOLINE — Supplemental Application (SOLA Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for cabergoline submitted by SOLA Pharmaceuticals, LLC, potentially updating labeling and/or indications for the dru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CABERGOLINE (CABERGOLINE)

Snippet

SUPPL AP for CABERGOLINE (CABERGOLINE)